Maybe it was inevitable in hindsight, but the accumulation and monetization of human data is now an industry — a commodity — of its own. As the internet's precursor technologies were being refined, the directive against using it for profit was gradually Read more [...]
Academic and research integrity cannot be a side project or an afterthought. Integrity and ethics must be central to everything we do and every decision we make. We must work to ensure that we are putting integrity at the forefront of our mission and operations. To achieve objectives mentioned it requests to respect the framework of integrity policies, processes and procedures at all institutional levels. Integrity policies, processes and procedures are an inseparable and significant part of the whole set of functions/activities within an institution that work together for the aim of the institution. Read more [...]
Newer genome editing technologies, such as CRISPR-Cas, are revolutionising scientific research and bringing about a myriad of potential applications in many fields. For science and technology to progress timely and efficiently, the societal debate must move forward at the same pace to help guide the direction of scientific research and to frame policy-making decisions. As this technology progresses, what will be the key questions to address as the public is engaged in these conversations? This article hints at some of them while a comprehensive list will be discussed at ESOF dilemma café session on Friday 13th –participate to find out! Read more [...]
On the EU level there are the anti-plagiarism policies not defined in the higher education sector, although plagiarism-related projects are being supported. Read more [...]
Despite your glass of Champagne, unfortunately you cannot forget the extreme difficulties we are facing to. Mind elevation is strongly required!
Fear has become a common factor in most of our societies. Conflicts are running everywhere revealing Read more [...]
Beyond a researcher's personal responsibility, the entire research system is not currently adequate to support greater level of research integrity. Read more [...]
In this issue, EuroScientist is venturing into exploring policy issues, which have implications for individuals in society. Specifically, this special issue focuses on the interplay between science and policy making when dealing with substance addiction.
Philosophical puzzles apply in public health too. In addiction, there is a subtle balance between the rights and responsibilities of the individual and the State. Particularly, when it comes to intervening in the lives of people addicted to substances such as tobacco, alcohol, or illegal drugs. Here, Julian Kinderlerer, professor of intellectual property law at Cape Town University, South Africa, who is also president of the European Group on Ethics in Science and New Technologies (EGE), outlines all the facets of the ethical dilemma associated with State intervention towards addiction, and places the role of scientists and ethicists in informing a balanced debate. Read more [...]
Half of all clinical trials never see the light of day. There are regulations in Europe and the US; they are often ignored. But public pressure has begun to push the pharmaceutical industries to make trial data available. However, in a world where industry, clinicians and medical publishers are complicit in not having clinical trials published in full, it may be necessary to give ownership of clinical data back to patients to gain greater transparency and accountability. Read more [...]
Research and innovation constantly change our world. From the Internet and mobile phones, to climate change and new cancer treatments, science and technology have the potential to transform our lives. These developments also create new risks and new ethical dilemmas. Responsible research and innovation (RRI) seeks to bring these issues into the open. It also aims to anticipate the consequences and directions of research and innovation. Read more [...]